Skip to content

Clinical trials

Phase 2 Digestive System Diseases trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Digestive System Diseases Phase: Phase 2 Country / region: China Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20191
20201
20211
20224
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting3
Unknown status3
Active, not recruiting2
Completed1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AusperBio Therapeutics Inc.1
Fudan University1
Jiangxi Provincial Cancer Hospital1
Mirum Pharmaceuticals, Inc.1
RenJi Hospital1
Shixiu Wu1
The First Affiliated Hospital with Nanjing Medical University1
The Second Affiliated Hospital of Fujian Medical University1
West China Hospital1
Zhejiang University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Digestive System Diseases10
Digestive System Neoplasms3
Gastrointestinal Diseases3
Gastrointestinal Neoplasms3
Neoplasms by Site3
Cholangitis2
Esophageal Diseases2
Esophageal Neoplasms2
Liver Cirrhosis, Biliary2
Liver Diseases2

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.